Skip to main content

Table 1 O-RADS MRI scores and clinicopathological characteristics of 361 EOTs

From: Tumor biomarkers contribute to the diagnosis and clinical management of the O-RADS MRI risk stratification system for epithelial ovarian tumors

Variable

Nature

BeEOT

BEOT

MEOT

Reference level

O-RADS MRI

2

3

4

5

2

3

4

5

3

4

5

0–5

No. (%)

16 (29.63)

36 (66.67)

1

(1.85)

1

(1.85)

1

(0.96)

53 (50.96)

40

(38.46)

10

(9.62)

28

(13.80)

89

(43.84)

86

(42.36)

/

Menopausal status

Premenopausal

10

25

1

1

0

40

37

9

18

45

32

/

Postmenopausal

6

11

0

0

1

13

3

1

10

44

54

Pathological type

Serous

10

9

1

0

0

36

27

4

17

40

65

/

Mucinous

4

25

0

0

1

10

9

4

5

9

1

Endometrioid

0

0

0

1

0

1

0

1

2

20

6

Clear cell

0

0

0

0

0

0

0

0

3

19

11

Serous-mucinous

2

2

0

0

0

6

4

1

1

1

1

Other

0

0

0

0

0

0

0

0

0

0

2

FIGO stage

I

/

1

47

31

8

13

40

14

I-IV

II

0

2

1

0

3

23

9

III-IV

0

4

8

2

12

26

63

  1. /: not applicable
  2. Other pathological types of MEOTs included 1 ovarian Brenner tumor and 1 ovarian carcinosarcoma